In a pilot randomised trial of 55 patients with myeloproliferative neoplasms (47 completed), 12-week supervised home exercise vs waitlist met all feasibility benchmarks and lowered LDH (−14.5 vs +4.0 U/L).
RCTn = 55
Ouellet et al. MPN-FIT: a randomized controlled pilot trial of supervised exercise in myeloproliferative neoplasms